References
Schreiter NF, Brenner W, Nogami M, Buchert R, Huppertz A, Pape UF, et al. Cost comparison of (111)In-DTPA-octreotide scintigraphy and (68)Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2012;39(1):72–82.
Wong KK, Wynn EA, Myles J, Ackermann RJ, Frey KA, Avram AM. Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors. Clin Nucl Med 2011;36(1):25–31.
BGBl. I, 22 July 2009; p. 1990
§2 No. 3, AMVHV, amendment I, BAnz, 6 August 2009, p. 2890
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruf, J. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT in Germany: two sides of two different coins. Eur J Nucl Med Mol Imaging 39, 723–724 (2012). https://doi.org/10.1007/s00259-011-2010-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-011-2010-y